RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
ADAM17
ADAM metallopeptidase domain 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24548422
NCBI chr 3:126,795,513...126,853,995
Ensembl chr 3:126,795,426...126,853,995
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
RGD
PMID:17604368 PMID:21479819
RGD:5686754 RGD:5686898
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADK
adenosine kinase
ISO
RGD
PMID:11123368
RGD:6482664
NCBI chr14:76,836,072...77,320,586
Ensembl chr14:76,836,095...77,322,416
G
ADRB3
adrenoceptor beta 3
ISO
mRNA:decreased expression:distal colon, mucosa (rat)
RGD
PMID:18492028
RGD:5684890
NCBI chr15:48,468,803...48,478,370
Ensembl chr15:48,475,144...48,479,562
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27783946
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
G
ALOX5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15821759
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
G
ANXA1
annexin A1
ISO
protein:increased expression:colon, neutrophil
RGD
PMID:10489933
RGD:2306920
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
APLN
apelin
ISO
RGD
PMID:17391779
RGD:1626177
NCBI chr X:106,236,746...106,246,563
Ensembl chr X:106,236,749...106,246,377
G
APOA4
apolipoprotein A4
ISO
human protein in mouse model
RGD
PMID:15254593
RGD:5685667
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
AQP7
aquaporin 7
ISO
associated with Infection;mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr10:33,098,746...33,130,245
G
ARG1
arginase 1
severity
ISO
RGD
PMID:28423665
RGD:39939041
NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
G
ARRB1
arrestin beta 1
ISO
protein:increased expression:colon (rat)
RGD
PMID:21066892
RGD:5509893
NCBI chr 9:9,516,944...9,597,446
Ensembl chr 9:9,516,947...9,597,976
G
ATP5F1D
ATP synthase F1 subunit delta
treatment
ISO
RGD
PMID:23840258
RGD:13792680
NCBI chr 2:77,216,430...77,219,301
Ensembl chr 2:77,216,436...77,222,632
G
BDNF
brain derived neurotrophic factor
ISO
protein:increased expression:dorsal root ganglion:
RGD
PMID:19932037
RGD:8657331
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
BMP6
bone morphogenetic protein 6
ISO
RGD
PMID:22361727
RGD:7242194
NCBI chr 7:5,058,817...5,208,868
Ensembl chr 7:5,058,817...5,210,270
G
BTK
Bruton tyrosine kinase
ameliorates
ISO
Associated with candidiasis
RGD
PMID:25379804
RGD:124713568
NCBI chr X:82,981,512...83,014,475
Ensembl chr X:82,981,515...83,014,573
G
CA1
carbonic anhydrase 1
ISO
protein:decreased expression:urine
RGD
PMID:31095872
RGD:408427353
NCBI chr 4:51,343,548...51,353,127
Ensembl chr 4:51,302,406...51,353,126
G
CAT
catalase
ISO
RGD
PMID:21463646
RGD:5130869
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CCKBR
cholecystokinin B receptor
ISO
RGD
PMID:15102523
RGD:2311333
NCBI chr 9:3,409,222...3,419,513
G
CCL2
chemokine (C-C motif) ligand 2
ISO
RGD
PMID:18690297
RGD:2307009
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:16399111
RGD:2307162
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
G
CD36
CD36 molecule
ISO
RGD
PMID:19117124
RGD:6893503
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
CD40
CD40 molecule
ISO
RGD
PMID:15591506
RGD:5508169
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CHEK2
checkpoint kinase 2
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:10617473 PMID:11053450 PMID:11479205 PMID:11719428 PMID:11967536 PMID:12094328 PMID:12533788 PMID:12690581 PMID:14648717 PMID:14648718 PMID:14648719 PMID:15087378 PMID:15095295 PMID:15122511 PMID:15466005 PMID:15488637 PMID:15492928 PMID:15520402 PMID:16257342 PMID:16492927 PMID:16880452 PMID:17085682 PMID:18172190 PMID:18381420 PMID:18759107 PMID:19338683 PMID:19768534 PMID:19805189 PMID:21779515 PMID:21807500 PMID:21876083 PMID:21956126 PMID:22006311 PMID:22058428 PMID:22419737 PMID:22811390 PMID:22994785 PMID:23109706 PMID:23469205 PMID:23652375 PMID:23946381 PMID:24033266 PMID:24713400 PMID:24884479 PMID:25431674 PMID:25583358 PMID:25741868 PMID:26467025 PMID:26845104 PMID:26884562 PMID:26976419 PMID:27223485 PMID:27269948 PMID:27433846 PMID:27711073 PMID:27751358 PMID:27798748 PMID:28135145 PMID:28195393 PMID:28492532 PMID:28503720 PMID:28514723 PMID:28727877 PMID:28734145 PMID:28779002 PMID:28802053 PMID:28874143 PMID:29351919 PMID:29489754 PMID:29522266 PMID:29909568 PMID:31300551 PMID:31993860 PMID:32119081 PMID:32285038 PMID:32295079 PMID:32383162 PMID:32531112 PMID:33471991 PMID:35534704 PMID:36222830 PMID:36623239 PMID:36744932 PMID:37055167 PMID:37149759 More...
NCBI chr14:45,699,833...45,967,350
Ensembl chr14:45,929,715...45,967,290
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
treatment
ISO
RGD
PMID:17543437
RGD:2298659
NCBI chr14:111,316,178...111,351,669
Ensembl chr14:111,315,141...111,351,868
G
CIITA
class II major histocompatibility complex transactivator
severity
ISO
protein:increased expression:T cells:constitutive expression of transgene increases severity ClinVar Annotator: match by term: Colitis
RGD ClinVar
PMID:17043423 PMID:25741868 PMID:28492532
RGD:5491188
NCBI chr 3:32,171,706...32,230,775
Ensembl chr 3:32,172,214...32,230,780
G
CRHR2
corticotropin releasing hormone receptor 2
ISO
mRNA, protein:decreased expression:intestine, myenteric nerve plexus
RGD
PMID:17586086 PMID:21330446
RGD:5131259 RGD:5490987
NCBI chr18:42,251,755...42,296,457
Ensembl chr18:42,251,749...42,295,467
G
CTSB
cathepsin B
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
G
CTSL
cathepsin L
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
G
CTSS
cathepsin S
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr 4:98,415,273...98,442,952
Ensembl chr 4:98,417,883...98,442,950
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
associated with Helicobacter Infections;mRNA:decreased expression:colon (mouse, Helicobacter hepaticus)
RGD
PMID:17242461
RGD:38549339
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:14738862
RGD:7257706
NCBI chr15:120,219,657...120,230,203
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:increased expression:large intestine epithelium
RGD
PMID:21374063
RGD:5147670
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
DUSP1
dual specificity phosphatase 1
severity
ISO
RGD
PMID:22461024
RGD:7771532
NCBI chr16:51,457,924...51,461,095
Ensembl chr16:51,458,020...51,461,086
G
ESR2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
FGF19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27580383
NCBI chr 2:3,583,027...3,586,985
Ensembl chr 2:3,582,828...3,587,752
G
FLNA
filamin A
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:25741868 PMID:28492532 PMID:30755392
NCBI chr X:124,889,934...124,915,000
Ensembl chr X:124,890,162...124,914,992
G
GCG
glucagon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22323126
NCBI chr15:68,800,557...68,810,268
Ensembl chr15:68,800,560...68,810,242
G
GHRL
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19617644
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
mRNA:increased expression:kidney:
RGD
PMID:23307618
RGD:7245473
NCBI chr16:66,162,318...66,208,868
G
HMOX1
heme oxygenase 1
treatment
ISO
protein:increased expression:colon: CTD Direct Evidence: therapeutic
RGD CTD
PMID:16365149 PMID:21444764 PMID:21853095 PMID:22261574
RGD:10766442 RGD:7207796
G
HP
haptoglobin
treatment
ISO
RGD
PMID:22457771
RGD:11041866
NCBI chr 6:14,980,382...14,985,245
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
ICOS
inducible T cell costimulator
ISO
protein:increased expression:T-cell
RGD
PMID:14731127
RGD:1624274
NCBI chr15:107,350,253...107,370,123
Ensembl chr15:107,350,203...107,370,119
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16717119 PMID:24548422
RGD:150573704
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24782617
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:17543437
RGD:2298659
NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
G
IL10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19238344 PMID:21807089 PMID:21949848 PMID:22119709 PMID:22461024 PMID:23771723 PMID:24314293 More...
RGD:7349385 RGD:7365024 RGD:7771532
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL17A
interleukin 17A
ISO
mRNA:increased expression:colon CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14962796 PMID:20881082 PMID:24548422
RGD:4781448 RGD:4888509
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL1RL1
interleukin 1 receptor like 1
severity
ISO
RGD
PMID:23172891
RGD:40400694
NCBI chr 3:51,868,549...51,902,454
Ensembl chr 3:51,846,792...51,951,383
G
IL33
interleukin 33
severity
ISO
RGD
PMID:23172891 PMID:28423665
RGD:39939041 RGD:40400694
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
IL4
interleukin 4
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:9389741 PMID:24314293
RGD:8142400
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL5
interleukin 5
ISO
protein: increased expression
RGD
PMID:22018693
RGD:5687148
NCBI chr 2:134,832,143...134,846,141
Ensembl chr 2:134,832,147...134,835,212
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22410118 PMID:24548422
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
ITGB2
integrin subunit beta 2
ISO
associated with Spirochaetales infections
RGD
PMID:11031123
RGD:6482227
NCBI chr13:207,514,281...207,544,108
Ensembl chr13:207,512,950...207,544,107
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
LOC100625897
lactase-phlorizin hydrolase
ISO
protein:decreased expression, increased expression:jejunum
RGD
PMID:17218984
RGD:1600240
NCBI chr15:16,094,277...16,154,467
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22969190 PMID:23810507 PMID:24548422
RGD:7204699
G
LRRK2
leucine rich repeat kinase 2
ISO
RGD
PMID:21983832
RGD:5508401
NCBI chr 5:71,800,337...71,945,828
Ensembl chr 5:71,800,225...71,945,828
G
MADCAM1
mucosal vascular addressin cell adhesion molecule 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16917232
NCBI chr 2:77,784,610...77,789,036
Ensembl chr 2:77,784,612...77,789,067
G
MC1R
melanocortin 1 receptor
ISO
RGD
PMID:16543288
RGD:5687320
NCBI chr 6:181,225...182,187
Ensembl chr 6:181,225...182,187
G
MIF
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:12105854 PMID:17324399
RGD:1641979
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR150-1
microRNA mir-150-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26937033
NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MSH2
mutS homolog 2
ISO
RGD
PMID:23883737
RGD:10412318
NCBI chr 3:93,082,958...93,163,556
Ensembl chr 3:93,081,219...93,163,585
G
MUC2
mucin 2, oligomeric mucus/gel-forming
treatment
ISO
mRNA:decreased expression:colon protein:decreased sulfation:descending colon
RGD
PMID:12395902 PMID:19220658 PMID:21949848 PMID:23395625
RGD:2324675 RGD:7349356 RGD:7349360 RGD:7349385
NCBI chr 2:689,363...719,542
Ensembl chr 2:689,364...710,330
G
NAMPT
nicotinamide phosphoribosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507
NCBI chr 9:106,119,896...106,162,126
Ensembl chr 9:106,119,899...106,294,586
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:30142311
RGD:42724458
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NOD1
nucleotide binding oligomerization domain containing 1
ISO
RGD
PMID:20921147
RGD:5508755
NCBI chr18:42,464,667...42,509,135
Ensembl chr18:42,432,050...42,512,264
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
mRNA:increased expression:colon
RGD
PMID:16891783 PMID:20921147 PMID:21471573
RGD:1600781 RGD:5508727 RGD:5508755
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
G
NOS2
nitric oxide synthase 2
ISO
mRNA:increased expression:colon CTD Direct Evidence: marker/mechanism mRNA:increased expression:colon (mouse)
RGD CTD
PMID:8698225 PMID:16866779 PMID:17449036 PMID:21930116
RGD:4891411 RGD:5509045
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NOS3
nitric oxide synthase 3
ISO
mRNA:increased expression:colon
RGD
PMID:17947450
RGD:2292124
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA, protein:increased expression:neuron
RGD
PMID:20638179
RGD:5684542
NCBI chr 4:93,219,509...93,237,944
Ensembl chr 4:93,219,516...93,255,981
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA, protein:increased expression:dorsal root ganglion
RGD
PMID:20638179
RGD:5684542
NCBI chr10:30,030,050...30,429,938
Ensembl chr10:30,033,405...30,429,882
G
PGF
placental growth factor
ISO
RGD
PMID:20142801
RGD:6483587
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:21244371
RGD:6482682
NCBI chr 9:106,698,200...106,748,217
Ensembl chr 9:106,698,207...106,745,099
G
PLA2G2A
phospholipase A2 group IIA
ISO
RGD
PMID:17982090
RGD:6482729
NCBI chr 6:78,327,728...78,339,546
Ensembl chr 6:78,327,319...78,330,699
G
PPARA
peroxisome proliferator activated receptor alpha
susceptibility
ISO
RGD
PMID:20650341
RGD:5509936
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
RGD
PMID:22126533
RGD:6484264
NCBI chr 8:17,841,844...18,527,953
Ensembl chr 8:17,841,844...17,946,992
G
PTGER4
prostaglandin E receptor 4
ISO
RGD
PMID:20833794
RGD:6483551
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11820457 PMID:17543437
RGD:2298659
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:nucleus CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18623154 PMID:23810507
RGD:2298776
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
REN
renin
treatment
ISO
RGD
PMID:24858618
RGD:125097500
NCBI chr 9:64,809,143...64,822,605
Ensembl chr 9:64,809,146...64,822,658
G
RETN
resistin
treatment
ISO
RGD
PMID:22630819
RGD:7207222
NCBI chr 2:71,484,164...71,485,577
Ensembl chr 2:71,484,169...71,485,616
G
SELL
selectin L
ISO
RGD
PMID:18054560
RGD:5685703
NCBI chr 4:81,306,363...81,325,296
Ensembl chr 4:81,306,353...81,326,444
G
SELP
selectin P
ISO
protein:increased expression:colon
RGD
PMID:19147805
RGD:2312310
NCBI chr 4:81,376,804...81,401,240
Ensembl chr 4:81,365,740...81,399,955
G
SELPLG
selectin P ligand
ISO
RGD
PMID:22009715
RGD:6218987
NCBI chr14:42,158,694...42,178,044
G
SI
sucrase-isomaltase
ISO
mRNA, protein:decreased expression:ileum
RGD
PMID:16964428
RGD:1625545
NCBI chr13:104,296,281...104,379,558
Ensembl chr13:104,296,283...104,379,478
G
SIRT1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19940103 PMID:24548422 PMID:24782617
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
G
SLC11A1
solute carrier family 11 member 1
ISO
RGD
PMID:19016783
RGD:5684975
NCBI chr15:120,434,100...120,446,396
Ensembl chr15:120,433,952...120,446,396
G
SOCS1
suppressor of cytokine signaling 1
ISO
RGD
PMID:16717119
RGD:150573704
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17551092
NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860
G
SYK
spleen associated tyrosine kinase
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:25741868 PMID:28492532 PMID:33782605
NCBI chr14:2,103,706...2,160,886
Ensembl chr14:2,056,670...2,161,171
G
TAC1
tachykinin precursor 1
ISO
RGD
PMID:18715640
RGD:2304260
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
G
TACR1
tachykinin receptor 1
ISO
RGD
PMID:18715640
RGD:2304260
NCBI chr 3:67,839,367...68,021,733
Ensembl chr 3:67,839,411...68,021,724
G
TACR2
tachykinin receptor 2
ISO
RGD
PMID:12490601 PMID:18715640
RGD:2304260 RGD:5147478
NCBI chr14:72,463,405...72,476,034
Ensembl chr14:72,462,046...72,475,554
G
TES
testin LIM domain protein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:39237074
NCBI chr18:29,895,878...29,936,248
Ensembl chr18:29,895,882...29,936,233
G
TFF1
trefoil factor 1
ISO
RGD
PMID:8836141
RGD:625375
NCBI chr13:205,687,558...205,691,512
Ensembl chr13:205,687,560...205,691,460
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24548422
NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581
G
TLR3
toll like receptor 3
ISO
mRNA:increased expression:large intestine mucosa (rat)
RGD
PMID:20011045
RGD:5128708
NCBI chr15:46,966,262...46,977,774
Ensembl chr15:46,969,006...46,979,291
G
TLR4
toll like receptor 4
ISO
protein:increased expression:colon
RGD
PMID:19002562 PMID:19924809
RGD:2312573 RGD:7794773
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507 PMID:24548422
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
TREM1
triggering receptor expressed on myeloid cells 1
severity
ISO
RGD
PMID:24453980
RGD:126925972
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
G
TST
thiosulfate sulfurtransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19647029
NCBI chr 5:10,749,264...10,759,623
Ensembl chr 5:10,746,890...10,759,622
G
UCN
urocortin
ISO
mRNA:altered expression:distal colon (rat)
RGD
PMID:21330446
RGD:5490987
NCBI chr 3:111,834,082...111,835,932
Ensembl chr 3:111,835,125...111,835,508
G
UCN2
urocortin 2
ISO
mRNA:increased expression:colon (rat)
RGD
PMID:17586086
RGD:5131259
NCBI chr13:31,261,196...31,261,824
Ensembl chr13:31,261,196...31,261,534
G
VCAM1
vascular cell adhesion molecule 1
ISO
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
VIP
vasoactive intestinal peptide
ISO
associated with Gram-Negative Bacterial Infections
RGD
PMID:19661153
RGD:5685605
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
G
VIPR2
vasoactive intestinal peptide receptor 2
ISO
RGD
PMID:21295288
RGD:5685384
NCBI chr18:396,379...466,408
Ensembl chr18:396,263...518,102
G
ACE
angiotensin I converting enzyme
ISO
protein:increased expression:small intestine, large intestine:extracellular space (mouse)
RGD
PMID:26401072
RGD:11555935
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACE2
angiotensin converting enzyme 2
severity
ISO
Ace2 inhibitor Ace2 knockout
RGD
PMID:19517214 PMID:22837003
RGD:40818307 RGD:40818410
NCBI chr X:12,099,849...12,152,204
Ensembl chr X:12,093,242...12,151,286
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28740344
RGD:13782278
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:28740344
RGD:13782278
NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
G
SERPINA1
serpin family A member 1
treatment
ISO
RGD
PMID:23835442
RGD:14695050
NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
G
IL23A
interleukin 23 subunit alpha
severity
ISO
RGD
PMID:26455347
RGD:11097134
NCBI chr 5:21,732,416...21,733,981
Ensembl chr 5:21,732,165...21,734,267
G
IL33
interleukin 33
severity treatment
ISO
RGD
PMID:32156806
RGD:40400894
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
ACE
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:17342403 PMID:24239644
RGD:40400720 RGD:40400748
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACER3
alkaline ceramidase 3
severity
ISO
mRNA,protein:decreased expression, decreased activity:colon:
RGD
PMID:26938296
RGD:35673322
NCBI chr 9:10,985,078...11,167,386
Ensembl chr 9:10,967,857...11,162,502
G
ADAM17
ADAM metallopeptidase domain 17
treatment
ISO
RGD
PMID:11884025
RGD:632022
NCBI chr 3:126,795,513...126,853,995
Ensembl chr 3:126,795,426...126,853,995
G
ADRB3
adrenoceptor beta 3
no_association
ISO
mRNA:unaltered expression:colon (rat)
RGD
PMID:11803250
RGD:5684894
NCBI chr15:48,468,803...48,478,370
Ensembl chr15:48,475,144...48,479,562
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:29572553
RGD:152995414
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:20179206
RGD:126781749
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,657...36,759,552
G
ATP5F1A
ATP synthase F1 subunit alpha
treatment
ISO
RGD
PMID:25689466
RGD:13703055
NCBI chr 1:95,738,789...95,750,835
Ensembl chr 1:95,733,090...95,750,841
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates
ISO
RGD
PMID:26037070
RGD:11537970
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,002,734...33,020,242
G
CD68
CD68 molecule
treatment
ISO
RGD
PMID:25004394
RGD:40925931
NCBI chr12:52,874,754...52,877,256
Ensembl chr12:52,874,785...52,877,695
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CSF1R
colony stimulating factor 1 receptor
ameliorates
ISO
RGD
PMID:23451116
RGD:150524300
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:16689657
RGD:11039462
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
G
CXCL8
C-X-C motif chemokine ligand 8
treatment
ISO
RGD
PMID:29655167
RGD:39939058
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
EREG
epiregulin
ISO
protein:increased expression:colonic mucosa (mouse)
RGD
PMID:20498653
RGD:39457688
NCBI chr 8:70,351,316...70,372,530
Ensembl chr 8:70,351,311...70,372,569
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:31160593
RGD:126779602
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:22368862
RGD:10054108
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FGF10
fibroblast growth factor 10
treatment
ISO
human protein in mouse model human gene product in mouse model human protein in mouse model with bacterial delivery system
RGD
PMID:10381813 PMID:11952999 PMID:19736360 PMID:23676805
RGD:126928132 RGD:126928133 RGD:127284855 RGD:127284874
NCBI chr16:28,695,465...28,779,953
Ensembl chr16:28,695,470...28,777,509
G
FGF7
fibroblast growth factor 7
treatment
ISO
human protein in mouse model
RGD
PMID:10219846
RGD:126928136
NCBI chr 1:122,215,878...122,278,705
Ensembl chr 1:122,215,882...122,277,750
G
FOXP3
forkhead box P3
treatment
ISO
mRNA:increased expression:mucosa: protein:increased expression:colon:
RGD
PMID:17229795 PMID:26925602 PMID:27498708 PMID:28733028
RGD:14975101 RGD:38455994 RGD:38455995 RGD:38549362
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
HAMP
hepcidin antimicrobial peptide
ISO
protein:increased expression:colon
RGD
PMID:24764672
RGD:11041628
NCBI chr 6:44,785,863...44,787,303
Ensembl chr 6:44,784,160...44,787,305
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr11:7,195,556...7,321,071
G
HSF1
heat shock transcription factor 1
ISO
protein:increased acetylation:colon (rat)
RGD
PMID:25608526
RGD:10402402
NCBI chr 4:463,531...486,483
Ensembl chr 4:463,393...486,473
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:10092309 PMID:29572553
RGD:11522714 RGD:152995414
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IFNG
interferon gamma
ISO
protein:increased expression:plasma:
RGD
PMID:15030379 PMID:27498708
RGD:10755756 RGD:14975101
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IFNGR1
interferon gamma receptor 1
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 1:27,037,151...27,061,095
Ensembl chr 1:27,037,165...27,061,093
G
IL10
interleukin 10
treatment
ISO
associated with Helicobacter Infections
RGD
PMID:16982822 PMID:25727887 PMID:27815529 PMID:29572553
RGD:11049170 RGD:11049485 RGD:14975260 RGD:152995414
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8978354
RGD:8551835
G
IL2
interleukin 2
ISO
RGD
PMID:16630696
RGD:8662978
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL23A
interleukin 23 subunit alpha
severity
ISO
mRNA:increased expression:colon (mouse)
RGD
PMID:24028683
RGD:39458035
NCBI chr 5:21,732,416...21,733,981
Ensembl chr 5:21,732,165...21,734,267
G
IL25
interleukin 25
treatment
ISO
RGD
PMID:19118508
RGD:39456129
NCBI chr 7:75,710,453...75,717,688
Ensembl chr 7:75,709,995...75,714,355
G
IL33
interleukin 33
severity treatment
ISO
RGD
PMID:25112700 PMID:28423665
RGD:39938951 RGD:39939041
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:16133010 PMID:16630696 PMID:27096537
RGD:11062139 RGD:11062146 RGD:8662978
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
IRF9
interferon regulatory factor 9
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 7:75,133,800...75,139,641
Ensembl chr 7:75,126,622...75,139,640
G
ITGA2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:16534417
RGD:11530069
NCBI chr16:32,336,240...32,440,311
Ensembl chr16:32,336,292...32,437,103
G
ITGA4
integrin subunit alpha 4
ISO
protein:increased expression:colon (rat)
RGD
PMID:12183646
RGD:729408
NCBI chr15:86,942,054...87,028,428
Ensembl chr15:86,947,240...87,030,364
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KCNMA1
potassium calcium-activated channel subfamily M alpha 1
ISO
mRNA, protein:increased expression:colon
RGD
PMID:23986198
RGD:10412026
NCBI chr14:79,345,382...80,106,337
Ensembl chr14:79,352,005...80,106,295
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KL
klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:20004202
RGD:10403055
NCBI chr11:9,427,236...9,479,251
Ensembl chr11:9,427,037...9,479,228
G
LOC110258578
interleukin-1 beta-like
treatment
ISO
RGD
PMID:31175857
RGD:14975282
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:27028006
RGD:13800882
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:29037916
RGD:13800567
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MIF
macrophage migration inhibitory factor
severity
ISO
RGD
PMID:15807847
RGD:36947390
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR155
microRNA mir-155
treatment
ISO
associated with Helicobacter Infections
RGD
PMID:21880981 PMID:28246471 PMID:28461115 PMID:28752563 PMID:30253332 PMID:30927737 More...
RGD:21079443 RGD:21079463 RGD:21079473 RGD:21081536 RGD:24922208 RGD:25314295
NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
G
MIR21
microRNA mir-21
ameliorates
ISO
RGD
PMID:23826144
RGD:41404691
NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:23323009
RGD:13207328
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:23323009
RGD:13207328
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPO
myeloperoxidase
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MSC
musculin
exacerbates no_association
ISO
RGD
PMID:33448336 PMID:36848960
RGD:596936211 RGD:596936221
NCBI chr 4:63,709,800...63,712,651
Ensembl chr 4:63,709,795...63,713,140
G
MYD88
MYD88 innate immune signal transduction adaptor
exacerbates
ISO
RGD
PMID:25362351
RGD:150521530
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:22350949
RGD:10412739
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:21642017
RGD:10413866
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
protein:increased expression:colonic mucosa:
RGD
PMID:22997830
RGD:13204727
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
G
NPY
neuropeptide Y
treatment
ISO
RGD
PMID:20533056
RGD:10448943
NCBI chr18:47,985,796...47,993,726
Ensembl chr18:47,985,725...47,992,667
G
PDGFRA
platelet derived growth factor receptor alpha
treatment
ISO
RGD
PMID:24115822
RGD:11080973
NCBI chr 8:40,966,568...41,021,440
Ensembl chr 8:40,967,493...41,021,441
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
RGD
PMID:24115822
RGD:11080973
NCBI chr 2:151,155,753...151,192,818
Ensembl chr 2:151,155,756...151,192,647
G
PHEX
phosphate regulating endopeptidase X-linked
ISO
mRNA:decreased expression:bone:
RGD
PMID:16890604
RGD:11556253
NCBI chr X:18,199,396...18,420,985
Ensembl chr X:18,203,174...18,418,004
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
susceptibility
ISO
RGD
PMID:20347874
RGD:38599183
NCBI chr 9:106,698,200...106,748,217
Ensembl chr 9:106,698,207...106,745,099
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:12100473
RGD:727388
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
RELA
RELA proto-oncogene, NF-kB subunit
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RNASEL
ribonuclease L
severity
ISO
RGD
PMID:23567782
RGD:40902808
NCBI chr 9:123,895,045...123,910,386
Ensembl chr 9:123,893,294...123,910,398
G
SLC11A1
solute carrier family 11 member 1
ISO
RGD
PMID:19116231
RGD:5684934
NCBI chr15:120,434,100...120,446,396
Ensembl chr15:120,433,952...120,446,396
G
SMAD3
SMAD family member 3
ISO
protein:increased expression:colon
RGD
PMID:30064196
RGD:597830080
NCBI chr 1:164,998,457...165,124,455
Ensembl chr 1:164,998,103...165,124,449
G
SMAD4
SMAD family member 4
susceptibility
ISO
RGD
PMID:23090737
RGD:12880038
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
G
SOCS3
suppressor of cytokine signaling 3
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:21296062 PMID:29572553
RGD:152995414 RGD:8661763
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
TNFRSF1A
TNF receptor superfamily member 1A
treatment
ISO
RGD
PMID:21296062
RGD:8661763
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
SERPINE1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:25656775
RGD:13208543
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
VEGFA
vascular endothelial growth factor A
ISO
RGD
PMID:15770733
RGD:1580570
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
IL1RN
interleukin 1 receptor antagonist
ISO
protein:increased concentration:serum (human)
RGD
PMID:9802632
RGD:6909134
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
susceptibility
ISO
RGD
PMID:15505619
RGD:1598568
NCBI chr 9:93,049,955...93,146,469
G
ACSM3
acyl-CoA synthetase medium chain family member 3
ISO
mRNA:decreased expression:colonic mucosa
RGD
PMID:21987487
RGD:7241281
NCBI chr 3:25,247,723...25,284,063
Ensembl chr 3:25,247,725...25,283,709
G
ADCY7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28067910
NCBI chr 6:34,521,503...34,586,384
Ensembl chr 6:34,519,180...34,585,779
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:16432373
RGD:5686726
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADRB2
adrenoceptor beta 2
ISO
protein:decreased expression:large intestine mucosa,spleen
RGD
PMID:22772914
RGD:7175063
NCBI chr 2:150,032,649...150,035,591
Ensembl chr 2:150,033,579...150,040,731
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ALOX12
arachidonate 12-lipoxygenase, 12S type
ISO
protein:increased expression:large intestine epithelium
RGD
PMID:7679252
RGD:5509621
NCBI chr12:52,401,861...52,414,913
Ensembl chr12:52,401,810...52,414,903
G
APLN
apelin
ISO
protein:increased expression:intestine
RGD
PMID:17391779
RGD:1626177
NCBI chr X:106,236,746...106,246,563
Ensembl chr X:106,236,749...106,246,377
G
APOA4
apolipoprotein A4
severity
ISO
DNA:missense mutation:cds:p.Q360H (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17206692 PMID:35999755
RGD:5685660
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
AQP7
aquaporin 7
severity
ISO
mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr10:33,098,746...33,130,245
G
ARPC2
actin related protein 2/3 complex subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18836448
NCBI chr15:120,297,122...120,328,795
Ensembl chr15:120,297,025...120,328,542
G
BCL6
BCL6 transcription repressor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:38164749
NCBI chr13:125,377,247...125,401,328
Ensembl chr13:125,377,250...125,393,330
G
BRINP3
BMP/retinoic acid inducible neural specific 3
ISO
mRNA,protein:decreased expression:intestine
RGD
PMID:25171508
RGD:14398484
NCBI chr10:2,963,237...3,367,629
Ensembl chr10:2,963,527...3,367,623
G
BTNL2
butyrophilin like 2
susceptibility
ISO
DNA:SNPs: : rs2294881,rs9268480,rs2076523(human)
RGD
PMID:19659809
RGD:9685032
NCBI chr 7:24,789,988...24,809,920
Ensembl chr 7:24,789,888...24,810,132
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
CARD9
caspase recruitment domain family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
G
CASP3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16306769 PMID:21887805
RGD:7488892
NCBI chr15:129,172,743...129,176,069
G
CCNY
cyclin Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr10:57,929,484...58,057,964
Ensembl chr10:57,929,244...58,086,872
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:21077277
RGD:6892920
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,286,467
G
CCR6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16306769
NCBI chr 1:2,016,600...2,034,172
Ensembl chr 1:2,018,608...2,019,821
G
CD40
CD40 molecule
ISO
protein:increased expression:intestine, epithelial cell
RGD
PMID:20133813
RGD:5490590
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDH3
cadherin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 6:18,190,971...18,236,184
Ensembl chr 6:18,191,664...18,235,862
G
CDKN1A
cyclin dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:15743319
RGD:8662406
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,354,672...32,363,761
G
CFB
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,034,332...24,041,179
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA:increased expression:intestine:
RGD
PMID:27051591
RGD:151667910
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
COL18A1
collagen type XVIII alpha 1 chain
ISO
Protein:increased expression:large intestine mucosa
RGD
PMID:17011522
RGD:1600887
NCBI chr13:207,907,835...207,984,082
Ensembl chr13:207,940,948...207,982,938
G
COL1A1
collagen type I alpha 1 chain
ISO
RGD
PMID:17939044
RGD:5688304
NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,004
G
COL6A3
collagen type VI alpha 3 chain
ISO
protein:increased expression:serum (human)
RGD
PMID:32245981
RGD:401900121
NCBI chr15:137,011,549...137,103,687
Ensembl chr15:137,011,433...137,103,709
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12133438 PMID:15955209
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr15:120,219,657...120,230,203
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:peripheral blood immature plasma cells
RGD
PMID:21087446
RGD:6480657
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
G
CXCR4
C-X-C motif chemokine receptor 4
ISO
mRNA:increased expression:peripheral blood immature plasma cells
RGD
PMID:21087446
RGD:6480657
NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:28811712
RGD:151665177
NCBI chr17:55,110,546...55,130,328
Ensembl chr17:55,110,590...55,130,363
G
DAP
death associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr16:250,212...322,075
Ensembl chr16:250,217...321,929
G
DPEP1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 6:361,187...385,757
Ensembl chr 6:361,197...376,616
G
DUOX2
dual oxidase 2
ISO
mRNA:increased expression:colon (human)
RGD
PMID:19759286
RGD:40924645
NCBI chr 1:126,620,468...126,641,406
Ensembl chr 1:126,620,510...126,641,406
G
ECM1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406
NCBI chr 4:98,615,776...98,633,081
Ensembl chr 4:98,615,778...98,621,836
G
EPHB2
EPH receptor B2
ameliorates
ISO
RGD
PMID:33722292
RGD:127285641
NCBI chr 6:80,649,098...80,849,979
Ensembl chr 6:80,650,740...80,843,567
G
ESR2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21593018
RGD:5147754
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:30122878
RGD:13792562
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:30122878
RGD:13792562
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FGF7
fibroblast growth factor 7
ISO
mRNA:increased expression:colon, lamina propria, myofibroblasts (human)
RGD
PMID:9358773
RGD:126928145
NCBI chr 1:122,215,878...122,278,705
Ensembl chr 1:122,215,882...122,277,750
G
GC
GC vitamin D binding protein
susceptibility
ISO
DNA:polymorphism:cds:p.T420K(human)
RGD
PMID:21832969
RGD:5509866
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
G
GHRL
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617644
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
G
GNA12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 3:2,002,494...2,105,937
Ensembl chr 3:2,004,471...2,105,952
G
GPR65
G protein-coupled receptor 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30616622
NCBI chr 7:109,978,913...109,997,688
Ensembl chr 7:109,985,307...109,989,280
G
GPX1
glutathione peroxidase 1
ISO
protein:decreased expression:erythrocyte
RGD
PMID:20186929
RGD:11352754
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
GPX2
glutathione peroxidase 2
disease_progression
ISO
protein:increased expression:large intestine (human)
RGD
PMID:18479189
RGD:152998902
NCBI chr 7:89,007,636...89,011,620
Ensembl chr 7:89,007,375...89,011,620
G
HERC2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr15:56,438,117...56,649,805
Ensembl chr15:56,438,148...56,649,792
G
HNF4A
hepatocyte nuclear factor 4 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr17:46,783,772...46,847,505
Ensembl chr17:46,783,777...46,847,500
G
HNMT
histamine N-methyltransferase
ISO
RGD
PMID:18340362
RGD:5509777
NCBI chr15:13,733,412...13,768,106
Ensembl chr15:13,732,680...13,768,199
G
HP
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 6:14,980,382...14,985,245
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:colon mucosa, epithelium (human)
RGD
PMID:22297444
RGD:5688753
NCBI chr 2:135,345,724...135,391,112
Ensembl chr 2:135,345,867...135,391,108
G
HTRA1
HtrA serine peptidase 1
ISO
protein:decreased expression:colonic epithelium,colonic mucosa (human)
RGD
PMID:28586045
RGD:152985530
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
ICAM1
intercellular adhesion molecule 1
ISO
mRNA:increased expression:substantia nigra (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15553846 PMID:20584104
RGD:4145388
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
ICOSLG
inducible T cell costimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr13:207,106,202...207,115,886
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:altered expression:colon
RGD
PMID:18938767
RGD:5686432
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058
G
IGF2
insulin like growth factor 2
disease_progression
ISO
RGD
PMID:16088202
RGD:5509966
NCBI chr 2:1,469,183...1,496,417
G
IKZF1
IKAROS family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:136,372,202...136,464,942
Ensembl chr 9:136,372,725...136,464,940
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18836448 PMID:20228799 PMID:26660358 PMID:28120341
RGD:14975153 RGD:14975255
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799 PMID:21297633
NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
G
IL17REL
interleukin 17 receptor E like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228798
NCBI chr 5:645,882...662,552
Ensembl chr 5:646,879...664,018
G
IL18RAP
interleukin 18 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 3:51,762,111...51,794,552
Ensembl chr 3:51,762,486...51,794,471
G
IL1R2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 3:52,367,434...52,406,393
Ensembl chr 3:52,367,437...52,406,334
G
IL1RN
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
RGD
PMID:8119534
RGD:6909136
G
IL23R
interleukin 23 receptor
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP,Haplotype: :rs1884444(human)
CTD RGD
PMID:18438406 PMID:19122664 PMID:20228799 PMID:23093364
RGD:8549574
NCBI chr 6:145,337,765...145,401,909
Ensembl chr 6:145,335,741...145,401,510
G
IL33
interleukin 33
severity treatment
ISO
mRNA:increased expression:sigmoid colon
RGD
PMID:21037074 PMID:25112700 PMID:28802904
RGD:39938951 RGD:39938966 RGD:40813742
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
IL7R
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr16:21,300,141...21,330,156
Ensembl chr16:21,300,111...21,329,585
G
IRF4
interferon regulatory factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38164749
NCBI chr 7:133,358...149,609
Ensembl chr 7:133,371...149,609
G
IRF5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr18:19,678,377...19,691,154
Ensembl chr18:19,678,687...19,691,243
G
JAK2
Janus kinase 2
ISO
DNA:SNP: :rs10758669 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20228799 PMID:21297633 PMID:22269120
RGD:6483020
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KIF21B
kinesin family member 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:23,444,997...23,491,081
Ensembl chr10:23,445,000...23,491,181
G
LAMB1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 9:107,670,120...107,747,242
Ensembl chr 9:107,671,152...107,772,269
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:12133438 PMID:15955209 PMID:20452301 PMID:22119283 PMID:24812904
RGD:10450593
G
LSP1
lymphocyte specific protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:1,261,957...1,295,891
Ensembl chr 2:1,262,079...1,295,887
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16640825 PMID:35999755
NCBI chr13:29,413,886...29,445,751
Ensembl chr13:29,413,886...29,445,739
G
MASP2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 6:71,224,637...71,243,041
Ensembl chr 6:71,224,637...71,243,874
G
MIR155
microRNA mir-155
ISO
miRNA:increased expression:colon miRNA:decreased expression:feces
RGD
PMID:29325325 PMID:29438285 PMID:29668922 PMID:30927737
RGD:21079443 RGD:21403682 RGD:24922207 RGD:24922213
NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
G
MIR31
microRNA mir-31
ISO
miRNA:increased expression:colon
RGD
PMID:29438285
RGD:21403682
NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809
G
MMP1
matrix metallopeptidase 1
ISO
RGD
PMID:18837084
RGD:7207395
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22119283
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20380826 PMID:22119283 PMID:24055189
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MST1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799
NCBI chr13:32,214,934...32,220,045
Ensembl chr13:32,214,937...32,219,902
G
MTRR
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G (human)
RGD
PMID:21947961
RGD:5508217
NCBI chr16:74,245,214...74,270,828
Ensembl chr16:74,245,228...74,270,783
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
mRNA:altered expression: :
RGD
PMID:12870797
RGD:2324685
NCBI chr 2:689,363...719,542
Ensembl chr 2:689,364...710,330
G
NKX2-3
NK2 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405 PMID:18438406 PMID:20228799
NCBI chr14:110,720,384...110,724,002
Ensembl chr14:110,720,394...110,723,995
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
G
ORMDL3
ORMDL sphingolipid biosynthesis regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr12:22,411,130...22,417,744
Ensembl chr12:22,411,587...22,417,736
G
PON1
paraoxonase 1
ISO
mRNA:decreased expression:colon
RGD
PMID:17664137
RGD:5509924
NCBI chr 9:74,943,646...74,974,720
Ensembl chr 9:74,926,048...74,974,723
G
PON3
paraoxonase 3
ISO
mRNA:decreased expression:colon
RGD
PMID:17664137
RGD:5509924
NCBI chr 9:74,983,040...75,017,947
Ensembl chr 9:74,991,277...75,017,942
G
PRDM1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 1:72,309,096...72,335,474
Ensembl chr 1:72,311,880...72,335,466
G
PSMG1
proteasome assembly chaperone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr13:202,762,509...202,775,601
Ensembl chr13:202,762,512...202,775,642
G
PTGER4
prostaglandin E receptor 4
ISO
RGD
PMID:21818367
RGD:6483532
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
RGD
PMID:17429720
RGD:2300267
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:17429720
RGD:2300267
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTPN2
protein tyrosine phosphatase non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 6:96,769,862...96,847,136
Ensembl chr 6:96,770,253...96,847,125
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15955209
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RIPK2
receptor interacting serine/threonine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 4:47,026,558...47,075,133
Ensembl chr 4:47,027,098...47,074,704
G
SELL
selectin L
ISO
DNA:polymorphism: :p.F206L (human)
RGD
PMID:19212205
RGD:13464267
NCBI chr 4:81,306,363...81,325,296
Ensembl chr 4:81,306,353...81,326,444
G
SELP
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21526498
RGD:6218993
NCBI chr 4:81,376,804...81,401,240
Ensembl chr 4:81,365,740...81,399,955
G
SLC11A1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human) DNA:transition, repeat:promoter:-237C>T (human)
CTD RGD
PMID:11929588 PMID:16059695 PMID:18340647
RGD:5684939 RGD:5684968
NCBI chr15:120,434,100...120,446,396
Ensembl chr15:120,433,952...120,446,396
G
SLC26A3
solute carrier family 26 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915573
NCBI chr 9:107,480,629...107,518,771
Ensembl chr 9:107,480,641...107,518,728
G
SPHK1
sphingosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr12:5,114,946...5,122,580
Ensembl chr12:5,114,947...5,120,083
G
STAT3
signal transducer and activator of transcription 3
ISO
DNA:SNP: :rs744166 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18438405 PMID:20228799 PMID:22269120
RGD:6483020
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
THBD
thrombomodulin
ISO
protein:decreased expression:colon, blood vessel
RGD
PMID:17557119
RGD:5685011
NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
G
TNF
tumor necrosis factor
treatment
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19617644 PMID:20452301 PMID:22119283 PMID:24812904 PMID:25204186 PMID:28120341 More...
RGD:10450577 RGD:10450593 RGD:14975153
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
TNFAIP3
TNF alpha induced protein 3
severity
ISO
mRNA,protein:increased expression, decreased expression:colonic mucosa (human)
RGD
PMID:28842689
RGD:151347619
NCBI chr 1:26,474,158...26,489,771
Ensembl chr 1:26,473,938...26,489,822
G
TNFSF15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 1:255,328,731...255,349,508
Ensembl chr 1:255,328,719...255,349,539
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15553846
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:colon, plasma
RGD
PMID:19013462
RGD:5684406
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VIP
vasoactive intestinal peptide
severity
ISO
mRNA:decreased expression:colon
RGD
PMID:22143367
RGD:5685619
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:17611633
RGD:5685618
NCBI chr13:26,036,610...26,073,168
Ensembl chr13:26,036,629...26,075,691
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all